Net Cash Provided by (Used in) Investing Activities of CERO THERAPEUTICS HOLDINGS, INC. from 30 Sep 2021 to 31 Dec 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
CERO THERAPEUTICS HOLDINGS, INC. annual and quarterly Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 30 Sep 2021 to 31 Dec 2023.
  • CERO THERAPEUTICS HOLDINGS, INC. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2023 was $100,000.
  • CERO THERAPEUTICS HOLDINGS, INC. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $7,944,740.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)

CERO THERAPEUTICS HOLDINGS, INC. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $7,944,740 -$188,784,136 01 Jan 2023 31 Dec 2023 10-K 02 Apr 2024 2023 FY
2022 $180,839,396* 01 Jan 2022 31 Dec 2022 10-K 02 Apr 2024 2023 FY

CERO THERAPEUTICS HOLDINGS, INC. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $100,000 -$100,000 01 Jan 2023 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q1 2022 $0 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q3 2021 $0 08 Jun 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.